drugset / Trial / NCT00389792
Efficacy and Safety Study of an Antiarrhythmic Drug to Treat Atrial Fibrillation in Patients With Pacemakers
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine the safety and efficacy of an investigational antiarrhythmic drug (ATI-2042) in the treatment of atrial fibrillation in patients with a dual chamber pacemaker.
Timeline
- Start
- 2006-07
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | BUDIODARONE | Small molecule | 200 mg | — |
| Comparator | BUDIODARONE | Small molecule | 400 mg | — |
| Comparator | BUDIODARONE | Small molecule | 600 mg | — |